CXCL1 and End Stage Liver Disease: Furthermore severity of liver cirrhosis, indicated by the model of end-stage liver disease (MELD) score, was comparable between patients who carried the A allele of the CXCL1 rs4047 polymorphism and patients without this allele (mean 16.7 versus 16.8; p=0.639).